As a metabolic pathogenic status, obesity is often accompanied by systemic chronic low-grade inflammation and elevated levels of immune markers such as leptin, IL-6, and TNF, which may influence tumor growth (9, 10). This evidence concerns the gene LEP and obesity due to melanocortin 4 receptor deficiency.